-
High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells
Vernooij, L., Bate-Eya, L. T., Alles, L. K., Lee, J. Y., Koopmans, B., Jonus, H. C., Schubert, N. A., Schild, L., Lelieveld, D., Egan, D. A., Kerstjens, M., Stam, R. W., Koster, J., Goldsmith, K. C., Molenaar, J. J. & Dolman, M. M. E., 1 Jun 2021, In: Molecular cancer therapeutics. 20, 6, p. 1161-1172 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion
van Golen, R. F., Reiniers, M. J., Marsman, G., Alles, L. K., van Rooyen, D. M., Petri, B., van der Mark, V. A., van Beek, A. A., Meijer, B., Maas, M. A., Zeerleder, S., Verheij, J., Farrell, G. C., Luken, B. M., Teoh, N. C., van Gulik, T. M., Murphy, M. P. & Heger, M., 1 Jun 2019, In: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 1865, 6, p. 1192-1200Research output: Contribution to journal › Article* › Academic › peer-review
-
Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study
Vogel, J. A., van Veldhuisen, E., Alles, L. K., Busch, O. R., Dijk, F., van Gulik, T. M., Huijzer, G. M., Besselink, M. G., van Lienden, K. P. & Verheij, J., 1 Jan 2019, In: Technology in cancer research & treatment. 18, p. 1533033819876899Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
